Title: Introduction to Human CD25/IL2RA HEK293T Stable Cell Line
Human CD25/IL2RA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity and application of the human CD25/IL2RA protein. This stable cell line is derived from HEK293T cells, a human embryonic kidney cell line that is commonly used in biomedical research. The stable expression of CD25/IL2RA in these cells allows for the production of a large quantity of this protein, making it an ideal model for studying its function and potential therapeutic applications.
Structure of Human CD25/IL2RA
CD25/IL2RA is a cell surface protein that is primarily expressed on activated T cells and regulatory T cells. It is a subunit of the interleukin-2 receptor (IL-2R) complex, which is responsible for binding to and signaling in response to the cytokine interleukin-2. The human CD25/IL2RA protein is composed of 272 amino acids and has a molecular weight of approximately 35 kDa. It contains a signal peptide, an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain is responsible for binding to IL-2, while the cytoplasmic domain is involved in signaling through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.
Activity of Human CD25/IL2RA
The primary function of CD25/IL2RA is to bind to IL-2 and form a high-affinity receptor complex with the IL-2Rβ and IL-2Rγ subunits. This complex is essential for IL-2 signaling and is involved in regulating T cell proliferation, survival, and differentiation. CD25/IL2RA is also expressed on regulatory T cells, which play a critical role in maintaining immune homeostasis and preventing autoimmunity. The binding of IL-2 to CD25/IL2RA on regulatory T cells leads to their activation and suppressive function, making it a potential therapeutic target for treating autoimmune diseases.
Application of Human CD25/IL2RA HEK293T Stable Cell Line
The stable expression of CD25/IL2RA in HEK293T cells allows for the production of a large quantity of this protein, making it a valuable tool for studying its function and potential therapeutic applications. One of the key applications of this stable cell line is in flow cytometry, a technique used to analyze and sort cells based on their surface markers. The expression of CD25/IL2RA on the surface of HEK293T cells allows for the identification and isolation of these cells, which can then be used for further analysis.
Moreover, this stable cell line can also be used to study the signaling pathways involved in IL-2 signaling and the role of CD25/IL2RA in T cell activation and differentiation. This can provide valuable insights into the mechanisms of immune response regulation and help in the development of new therapies for immune-related disorders.
In addition, the stable expression of CD25/IL2RA in HEK293T cells can also be used for drug screening and discovery. As CD25/IL2RA is a potential therapeutic target for autoimmune diseases, this stable cell line can be used to screen for compounds that can inhibit its function and potentially serve as new treatments for these conditions.
Conclusion
In summary, Human CD25/IL2RA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human CD25/IL2RA protein. Its stable expression in HEK293T cells allows for the production of a large quantity of this protein, making it an ideal model for studying its function and potential therapeutic applications. With its potential applications in flow cytometry, signaling pathway analysis, and drug discovery, this stable cell line is an essential resource for researchers studying the immune system and autoimmune diseases.
There are no reviews yet.